Drugs & Targets FDA approves Tafinlar and Mekinist for NSCLC with BRAF V600E mutation June 23, 2017Vol.43 No.25
Drugs & Targets FDA approves first companion diagnostic test to screen for multiple NSCLC therapies June 23, 2017Vol.43 No.25
Drugs & Targets FDA rejects Pfizer’s marketing application for Epogen biosimilar June 23, 2017Vol.43 No.25
Drugs & Targets FDA approves betrixaban for the prophylaxis of venous thromboembolism in adult patients June 23, 2017Vol.43 No.25
Drugs & Targets FDA accepts Amgen’s application to expand indication for Xgeva June 23, 2017Vol.43 No.25
In Brief National accreditation program for rectal cancer accepting applications from hospitals June 23, 2017Vol.43 No.25
Senate appropriations subcommittee members vow to resist Trump proposal to cut NIH budget June 23, 2017Vol.43 No.25By Claire Dietz
